Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771446 · ClinicalTrials.gov registry record · Phase 1
Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency
A Phase 1 study, sponsored by Vital Therapies.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00771446 is a Phase 1 study that has completed, run by Vital Therapies. The registered enrollment target is 18 participants.
The verdict
NCT00771446, a Phase 1 study, has completed, sponsored by Vital Therapies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Evaluate on how well the ELAD system works in treating people with liver failure.
Interventions
- OTHER Standard of care treatment
- BIOLOGICAL ELAD plus standard of care treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771446
The ClinicalTrials.gov registry entry for NCT00771446 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vital Therapies, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care treatment is the first listed.
NCT00771446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771446 about?
NCT00771446 is a clinical study titled "Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency". Evaluate on how well the ELAD system works in treating people with liver failure.
What is the current status of trial NCT00771446?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2008-10. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00771446?
The interventions under investigation include: Standard of care treatment (OTHER), ELAD plus standard of care treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT00771446?
This trial is sponsored by Vital Therapies, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.